Human ErbB2/Her2 Herstatin Isoform Antibody Summary
Thr23-Gly419
Accession # AAD56009
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: ErbB2/Her2
Herstatin is a secreted 68 kDa glycoprotein encoded by an alternate transcript of the Her2/neu (ErbB2) gene containing the N-terminal 304 amino acids (aa) of subdomain I and II, and 79 intron-encoded aa at the C-terminus. It is an endogenous inhibitor of the EGF receptor family that disrupts receptor interactions and inhibits growth of tumor cells that overexpress Her2.
Product Datasheets
Citations for Human ErbB2/Her2 Herstatin Isoform Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
11
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
iPSC-derived beta cells model diabetes due to glucokinase deficiency.
Authors: Hua H, Shang L, Martinez H et al.
J Clin Invest
-
Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters
Authors: Li, C;Han, X;Wang, J;Liu, F;Zhang, Y;Li, Z;Lu, Z;Yue, Y;Xiang, J;Li, X;
International journal of molecular sciences
-
Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism
Authors: Laura D'Ignazio, Ricardo S. Jacomini, Bareera Qamar, Kynon J. M. Benjamin, Ria Arora, Tomoyo Sawada et al.
eNeuro
-
Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease
Authors: Mi-Young Son, Mi-Ok Lee, Hyejin Jeon, Binna Seol, Jung Hwa Kim, Jae-Suk Chang et al.
Experimental & Molecular Medicine
-
An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils
Authors: Huan-Ting Lin, Hideki Masaki, Tomoyuki Yamaguchi, Taizo Wada, Akihiro Yachie, Ken Nishimura et al.
Molecular Therapy - Methods & Clinical Development
-
Derivation of induced pluripotent stem cells from orangutan skin fibroblasts
Authors: Krishna Ramaswamy, Wing Yan Yik, Xiao-Ming Wang, Erin N. Oliphant, Wange Lu, Darryl Shibata et al.
BMC Research Notes
-
Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus–Merzbacher disease patient with a partial PLP1 duplication
Authors: Keiko Shimojima, Takahito Inoue, Yuki Imai, Yasuhiro Arai, Yuta Komoike, Midori Sugawara et al.
Journal of Human Genetics
-
Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis
Authors: JL Weirather, M de Cesare, Y Wang, P Piazza, V Sebastiano, XJ Wang, D Buck, KF Au
F1000Res, 2017-02-03;6(0):100.
-
Reconstruction of Alzheimer's Disease Cell Model In Vitro via Extracted Peripheral Blood Molecular Cells from a Sporadic Patient
Authors: S Liu, Y Zhao, X Su, C Zhou, P Yang, Q Lin, S Li, H Tan, Q Wang, C Wang, Q Wu
Stem Cells International, 2020-12-18;2020(0):8897494.
-
Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive state
Authors: H Ozaki, H Suga, M Sakakibara, M Soen, N Miyake, T Miwata, S Taga, T Nagai, M Kano, K Mitsumoto, T Miyata, T Kobayashi, M Sugiyama, T Onoue, H Takagi, D Hagiwara, S Iwama, R Banno, G Iguchi, Y Takahashi, K Muguruma, H Inoue, H Arima
Scientific Reports, 2022-10-17;12(1):17381.
-
Transcriptional Programming of Human Mechanosensory Neuron Subtypes from Pluripotent Stem Cells
Authors: AR Nickolls, MM Lee, DF Espinoza, M Szczot, RM Lam, Q Wang, J Beers, J Zou, MQ Nguyen, HJ Solinski, AA AlJanahi, KR Johnson, ME Ward, AT Chesler, CG Bönnemann
Cell Rep, 2020-01-21;30(3):932-946.e7.
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human ErbB2/Her2 Herstatin Isoform Antibody
There are currently no reviews for this product. Be the first to review Human ErbB2/Her2 Herstatin Isoform Antibody and earn rewards!
Have you used Human ErbB2/Her2 Herstatin Isoform Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image